Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.850
-0.090 (-4.64%)
Jul 3, 2025, 1:00 PM - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $87.15 million as of July 3, 2025. Its market cap has decreased by -21.37% in one year.
Market Cap
87.15M
Enterprise Value
20.45M
1-Year Change
-21.37%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $87.15M, a decrease of -89.16%. That is a compound annual growth rate of -39.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 87.15M | -1.07% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |